Healthcare Leaders Income Fund

Healthcare Leaders Income Fund
Harvest Portfolios Group Inc.

Harvest Portfolios Group Inc.

October 29, 2014 17:50 ET

Healthcare Leaders Income Fund Files Preliminary Prospectus

TORONTO, ONTARIO--(Marketwired - Oct. 29, 2014) -

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Harvest Portfolios Group Inc. (the "Manager") is pleased to announce that a preliminary prospectus for Healthcare Leaders Income Fund (the "Fund") has been filed with, and a receipt therefor issued by, the securities regulatory authorities in each of the provinces and territories of Canada.

The Fund proposes to issue Units at a price of $10.00 per Unit (the "Offering").

The Fund's investment objectives are to provide Unitholders with (i) the opportunity for capital appreciation; (ii) monthly cash distributions; and (iii) lower overall volatility of Portfolio returns than would otherwise be experienced by owning Equity Securities of Healthcare Leaders directly.

The Fund will invest in an equally-weighted Portfolio of Equity Securities of 20 Healthcare Issuers, which are issuers listed on a North American stock exchange that are included in the health care sector of the Global Industry Classification Standards and whose underlying business includes, but is not limited to, the provision of healthcare goods and services, including manufacturing and distributing healthcare products, equipment, supplies and technologies, producing and marketing of pharmacueticals and biotechnology products, and/or engaging in research and development that (i) have a market capitalization of at least US$5 billion, and (ii) have options in respect of their Equity Securities listed on a recognized options exchange.

In order to seek to generate additional returns, Highstreet Asset Management Inc. (the "Investment Manager" or "Highstreet") may sell call options each month on up to 33% of each of the Equity Securities held in the Portfolio.

Highstreet will be responsible for the execution of the Fund's overall investment strategy, including managing the composition of the Portfolio.

The indicative distribution amount will be $0.0583 per Unit per month ($0.70 per annum), representing an annual cash distribution of 7% based on the per Unit issue price.

The syndicate of agents for the Offering is being co-led by BMO Capital Markets, CIBC and Scotiabank, and includes National Bank Financial Inc., Canaccord Genuity Corp., Global Securities Corporation, GMP Securities L.P., Raymond James Ltd., Desjardins Securities Inc., Dundee Securities Ltd., Industrial Alliance Securities Inc., Mackie Research Capital Corporation and Manulife Securities Incorporated. (collectively, the "Agents").

Certain statements included in this news release constitute forward-looking statements, including, but not limited to, those identified by the expressions "expect", "intend", "will" and similar expressions to the extent they relate to the Fund, the Manager and/or the Investment Manager. The forward-looking statements are not historical facts but reflect the Fund's, the Manager's, and/or the Investment Manager's current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Although the Fund, the Manager, and/or the Investment Manager believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, readers are cautioned not to place undue reliance on such statements due to the inherent uncertainty therein. The Fund, the Manager and/or the Investment Manager undertakes no obligation to update publicly or otherwise revise any forward-looking statement or information whether as a result of new information, future events or other such factors which affect this information, except as required by law.

A preliminary prospectus dated October 29, 2014 (the "Prospectus") containing important information relating to these securities has been filed with securities commissions or similar authorities in each of the provinces and territories of Canada. The Prospectus is still subject to completion or amendment. Copies of the Prospectus may be obtained from any of the Agents. There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued.

All capitalized terms noted herein but not defined are as defined in the Prospectus.

For additional information or a copy of the Prospectus, please contact your registered financial advisor.

Contact Information